Complement factor C3 deposition and serum resistance in isogenic capsule and lipooligosaccharide sialic acid mutants of serogroup B Neisseria meningitidis
about
Identification of a novel sialic acid transporter in Haemophilus ducreyiLipooligosaccharide P(k) (Galalpha1-4Galbeta1-4Glc) epitope of moraxella catarrhalis is a factor in resistance to bactericidal activity mediated by normal human serumClinical and laboratory evidence for Neisseria meningitidis biofilms.CD46-independent binding of neisserial type IV pili and the major pilus adhesin, PilC, to human epithelial cellsThe (alpha2-->8)-linked polysialic acid capsule and lipooligosaccharide structure both contribute to the ability of serogroup B Neisseria meningitidis to resist the bactericidal activity of normal human serum.The capsular polysaccharide of Burkholderia pseudomallei contributes to survival in serum by reducing complement factor C3b depositionProtection by natural human immunoglobulin M antibody to meningococcal serogroup B capsular polysaccharide in the infant rat protection assay is independent of complement-mediated bacterial lysis.Sialylation of lipooligosaccharide cores affects immunogenicity and serum resistance of Campylobacter jejuniRole of capsule in the pathogenesis of fowl cholera caused by Pasteurella multocida serogroup A.Sialic acid involved in hypermucoviscosity phenotype of Klebsiella pneumoniae and associated with resistance to neutrophil phagocytosis.Phase variation of Campylobacter jejuni 81-176 lipooligosaccharide affects ganglioside mimicry and invasiveness in vitroThe interplay between Siglecs and sialylated pathogensMeningococcal disease and the complement system.Opc expression, LPS immunotype switch and pilin conversion contribute to serum resistance of unencapsulated meningococci.Meningococcal group W-135 and Y capsular polysaccharides paradoxically enhance activation of the alternative pathway of complement.Comparative Genomics Reveal That Host-Innate Immune Responses Influence the Clinical Prevalence of Legionella pneumophila Serogroups.Revisiting the host as a growth mediumMolecular characterization of the interaction between sialylated Neisseria gonorrhoeae and factor H.α-2,3-sialyltransferase expression level impacts the kinetics of lipooligosaccharide sialylation, complement resistance, and the ability of Neisseria gonorrhoeae to colonize the murine genital tractIdentification of the hypervirulent lineages of Neisseria meningitidis, the ST-8 and ST-11 complexes, by using monoclonal antibodies specific to NmeDI.Lactate acquisition promotes successful colonization of the murine genital tract by Neisseria gonorrhoeae.Host-like carbohydrates promote bloodstream survival of Vibrio vulnificus in vivo.Differential Killing of Salmonella enterica Serovar Typhi by Antibodies Targeting Vi and Lipopolysaccharide O:9 AntigenTranscriptomic buffering of cryptic genetic variation contributes to meningococcal virulence.A novel sialic acid binding site on factor H mediates serum resistance of sialylated Neisseria gonorrhoeae.Available carbon source influences the resistance of Neisseria meningitidis against complement.Defining targets for complement components C4b and C3b on the pathogenic neisseriaeNeisseria meningitidis Polynucleotide Phosphorylase Affects Aggregation, Adhesion, and Virulence.Functional comparison of the binding of factor H short consensus repeat 6 (SCR 6) to factor H binding protein from Neisseria meningitidis and the binding of factor H SCR 18 to 20 to Neisseria gonorrhoeae porin.Factor H and neisserial pathogenesis.Naturally acquired passive protective activity against Neisseria meningitidis Group C in the absence of serum bactericidal activity.Role of lipopolysaccharide sialylation in serum resistance of serogroup B and C meningococcal disease isolates.Complement activation and formation of the membrane attack complex on serogroup B Neisseria meningitidis in the presence or absence of serum bactericidal activityComparative genome biology of a serogroup B carriage and disease strain supports a polygenic nature of meningococcal virulenceRole of YadA, Ail, and Lipopolysaccharide in Serum Resistance of Yersinia enterocolitica Serotype O:3.NeuA sialic acid O-acetylesterase activity modulates O-acetylation of capsular polysaccharide in group B StreptococcusCharacterization of an antibody depletion assay for analysis of bactericidal antibody specificity.Sialylation of group B streptococcal capsular polysaccharide is mediated by cpsK and is required for optimal capsule polymerization and expression.Biochemical characterization of a Neisseria meningitidis polysialyltransferase reveals novel functional motifs in bacterial sialyltransferases.
P2860
Q24534699-B9988B0A-84A5-4CFE-BF77-BC6AE2C82726Q33599918-7C34E78F-7DD1-4F9B-B323-EE8993FD0926Q33685515-2AD2BB03-0235-4E51-9AD2-2DAAFC07F36AQ33768892-C0E28F34-3AFE-49AA-940B-EFF3F58BE127Q33769638-BC714F55-FBE5-4D6A-A485-11F0DD6FCD25Q33798900-E26A1E70-E4CF-469B-8BFE-D1EE25B5DC23Q33946852-BA129962-BC0E-48CB-B25A-0AE6FC4DBF49Q34005157-98610A1E-48BA-4277-A314-BBF73CD67B14Q34006932-136129D4-A294-44AC-B609-02DD28D5392FQ34071034-53CC50EF-C74A-4984-A9AC-5EC9B369A363Q34116680-AE60039E-2AFA-470E-81EE-1BC8D8E75292Q34208951-CEADAA28-3E21-41F3-A2C8-AF5E71B260CCQ34376170-E75DA41C-50B1-4EF1-BE8E-6E3C2DBC42E3Q34428168-3088A038-B856-4238-A726-693CE2E9A56EQ34624357-9FA40409-C207-4DEB-8D9A-A08043478460Q34796849-80EE45A4-69DB-4682-8052-8AB38FF1CE1CQ35046832-07CE2A52-ED89-4BEF-8BBE-410B6E853DE9Q35063071-73F2616C-CF13-4F52-B9AB-B1E68EB7916DQ35072338-DA499D68-46B5-4703-AE49-ED3F5C9A88EEQ35637385-C9132AB1-8A72-4688-9E99-9B5072345377Q35689380-7870DABD-8FCA-4457-8A5F-8D951CB3F902Q35833811-0CDAD163-0E61-4FBF-A6EB-CADC830E3BC1Q35888059-CB12929A-E766-4D32-B660-37E39720DFEFQ36340099-4B65D5DF-B625-4B88-825C-E0C7CFB2638CQ36400453-A27F239C-62B7-4C5F-BD2F-71001252B6B1Q36402993-7010D3ED-C324-4B26-BEA1-9BF12DE03C25Q36422066-9C439B0B-19F4-43FA-8A83-4B7786D33327Q36888510-D608660C-822C-4983-BDAC-97A45A7DC9F4Q37191341-53D783EE-4577-4A5E-9026-40C947B77062Q37401428-43A2CB31-E301-4BBC-8379-3650F712E80AQ37523580-022992B0-8C5A-47F9-8693-D3F5F963FC41Q39509812-1E4F2495-C85E-4915-8728-15288D5D9899Q39655597-D080C9A1-7211-46E1-A784-ABD013023851Q39667409-74FA0483-DB6C-489B-8614-5DF9E60E0BB0Q41459015-B91156B4-3BB7-4F7B-9ACA-F88B322ABBBEQ41601349-CA1AF0FC-D6E8-4BC1-BB87-3AE70FE15C81Q41774048-4680000C-AC68-4FB4-853E-73E196BDD590Q42863338-91FC95A8-9D19-442B-AF74-A0A2F902C1D2Q42911223-5B881167-EFAC-43E9-8173-C7E617AF9266
P2860
Complement factor C3 deposition and serum resistance in isogenic capsule and lipooligosaccharide sialic acid mutants of serogroup B Neisseria meningitidis
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Complement factor C3 depositio ...... group B Neisseria meningitidis
@en
type
label
Complement factor C3 depositio ...... group B Neisseria meningitidis
@en
prefLabel
Complement factor C3 depositio ...... group B Neisseria meningitidis
@en
P2093
P2860
P1476
Complement factor C3 depositio ...... group B Neisseria meningitidis
@en
P2093
Atkinson JP
Weinberger A
P2860
P304
P407
P577
1997-10-01T00:00:00Z